The Art and Science of Cross Border Business Development and Licensing | LSI Europe '24

This panel took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.The panelists discussed the key considerations for cross-border business development in emerging markets. Subjects like the intricacies of companies entering US markets or receiving government support in entering markets like India and the Middle East are covered throughout this discussion.This panel featured:Ajay Nair — The Mullings Group CompaniesPieter Wijffels — NLC Health VenturesEliane Schutte — XeltisJeffrey Sirek — PRIA HealthcareSabine Kapasi — Enira ConsultingJoin us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summitsFollow us on social:LinkedIn: https://www.linkedin.com/company/life-science-intelligence/Twitter: https://twitter.com/lsintelligenceInstagram: https://www.instagram.com/lifescienceintelligence/Facebook: https://www.facebook.com/LifeScienceIntelligence/Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw

There are no comments yet.

Please log in to write the first comment.